Uppsala as Life Science City – What can we learn from successful companies?
In an increasingly international competition, the conditions are decisive for where companies choose to grow. Access to competence (employees and consultants), financing, facilities for manufacturing and communications are key factors.
How can Uppsala’s goal of 3500 new Life Science jobs become reality? Based on lessons learned from successful companies, we discuss how the conditions for strengthening the Life Science Cluster in Uppsala can be developed.
Welcome to a panel debate organized by Uppsala BIO and Knightec.
Date: Tuesday 5 February 2019
Time: 16.30–19.00. Coffee will be served from 16.30. Debate starts at 17.00 followed by networking and light refreshments.
Location: Knightec, Dragarbrunnsgatan 45, Uppsala
The seminar can be held in English upon request. Please notify in the form.
Thomas Malmer, CMO Knightec, Moderator
Thomas Malmer is Marketing Manager at Knightec. He has a long experience of developing collaborative initiatives in business, research and politics, as well as driving policy issues, e.g. in life sciences.
Eugen Steiner, Partner Health Cap
Eugen Steiner is a partner at Health Cap. As entrepreneur and CEO, he has started and run several life science companies in different phases, in Sweden as well as internationally. Eugen has been the CEO for the start-up companies Biotage and Affibody.
Erik Forsberg, Ph.D., Associate Professor, CEO Uppsala BIO
Erik Forsberg works with everything from strategic impact to operational activities to implement various types of supportive initiatives in the industry, university and society interface. His goal is to drive system improvements that create better conditions to develop the field of life sciences in Uppsala.
Lotta Ljungqvist, President & CEO GE Nordic
Lotta Ljungqvist is President and CEO of GE Nordics, responsible for GE’s overall growth in the region. She is also CEO Testa Center in Uppsala, a public-private partnership to support growth in the industrialization of bioprocess biology and technology innovation.
Sara Mangsbo, Associate Professor and Assistant Principal in biological medicine at Uppsala University
Sara Mangsbo is Associate Professor and Assistant Principal in biological medicine at Uppsala University where she leads a research group working with immuno-oncology. Sara also works as Head of Development at Ultimovacs AB and has founded Immuneed AB.
Erik Olaisson, B.Sc., Business Development, Uppsala BIO
Erik Olaisson have broad experience from large and small companies and have developed pharmaceutical, biotechnological and medical technology products. Erik is still operational and strategically active in his own consulting company, which is an advantage in his work at Uppsala BIO.
Helena Ströberg, M.Sc., Business Development. “I am passionate about creating opportunities so that players in the life science industry become more successful, thus contributing to growth in our region as well as in Sweden.”